FineMark National Bank & Trust’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,012
Closed -$106K 1170
2016
Q4
$106K Sell
1,012
-100
-9% -$10.8K 0.01% 455
2016
Q3
$140K Buy
1,112
+168
+18% +$21.4K 0.02% 383
2016
Q2
$130K Buy
944
+41
+5% +$5.42K 0.01% 376
2016
Q1
$125K Sell
903
-83
-8% -$11.4K 0.01% 375
2015
Q4
$159K Buy
986
+86
+10% +$13.3K 0.02% 357
2015
Q3
$120K Sell
900
-133
-13% -$17.4K 0.02% 416
2015
Q2
$118K Buy
1,033
+10
+1% +$1.2K 0.02% 445
2015
Q1
$122K Buy
1,023
+77
+8% +$10.3K 0.02% 436
2014
Q4
$138K Sell
946
-85
-8% -$10.7K 0.02% 424
2014
Q3
$136K Buy
1,031
+242
+31% +$31.9K 0.02% 405
2014
Q2
$99K Buy
789
+28
+4% +$3.62K 0.02% 475
2014
Q1
$122K Sell
761
-75
-9% -$12.3K 0.02% 410
2013
Q4
$112K Buy
836
+8
+1% +$1.03K 0.02% 405
2013
Q3
$90K Buy
828
+46
+6% +$4.97K 0.02% 449
2013
Q2
$66K Buy
+782
New +$70K 0.02% 496

Other funds holding ATHN

FineMark National Bank & Trust's ATHN Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Athenahealth, Inc. (ATHN) in Q1 2017, closing a stake of 1,012 shares — an estimated $106K sold.

FineMark National Bank & Trust first reported a position in ATHN in Q2 2013 and held it in 15 quarters. The position peaked at $159K in Q4 2015. 226 funds tracked by Wall St. Rank hold ATHN as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Athenahealth, Inc. position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 1,012 Athenahealth, Inc. shares in Q1 2017, an estimated $106K.
  • FineMark National Bank & Trust first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Athenahealth, Inc. position peaked at $159K in Q4 2015.
  • 226 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.